Find a Diabetes Clinical Study at BRI

Easily find a diabetes clinical trial at BRI through our listings below. The Diabetes Clinical Research Program has a full spectrum of studies for participants throughout the disease process. Research ranges from prevention trials for high-risk individuals, to studies to save insulin producing cells in the newly diagnosed, to therapies to help manage diabetes and reduce possible disease complications. Voluntary participation helps those now and in the future battle type 1 diabetes.

ag019_teplizumab

AG019 & Teplizumab

Recently diagnosed individuals who meet the following major criteria may be eligible if they:

  • were diagnosed with type 1 diabetes within 150 days
  • are 12 – 40 years of age
  • test positive for at least one diabetes-related autoantibody
  • are in good general health

BRIDge Study of Type 1 Diabetes

  • For individuals who have recent onset or long-standing type 1 diabetes

    TrialNet Pathway to Prevention Study

    • For individuals who are 2.5-45 years of age with a first-degree relative (parent, child, sibling) with type 1 diabetes
    • For individuals who are 2.5-20 years of age with a second-degree relative (grandparent, aunt, uncle, niece, nephew, cousin or half-sibling) with type 1 diabetes

    Waking Beta Cell Study

     

    Waking Beta Cells Study

    For individuals who:

    • were diagnosed with type 1 diabetes at least three years ago
    • are 18-50 years of age
    • live in the greater Seattle area
    • are in good general health

    Join Our Registry

    • For individuals who have recent onset or long-standing type 1 diabetes
    • For family members of individuals with type 1 diabetes
    Email or text messaging is not a secure medium for sending or receiving sensitive or personal information, including health information. Your use of email or text messaging with BRI constitutes consent to such communication methods.